Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

RZLT.US Logo

RZLT.US - Current Price

$2.51

Company Information

▼
Company Name
Rezolute Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US76200L3096
CIK: 0001509261
CUSIP: 76200L309
Currency: USD
Full Time Employees: 75
Phone: 650 206 4507
Website: https://www.rezolutebio.com
Fiscal Year End: June
IPO Date: May 01, 2014
Description:

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.

Address:

275 Shoreline Drive, Redwood City, CA, United States, 94065

Directors & Officers

▼
Name Title Year Born
Mr. Nevan Charles Elam J.D. Founder, CEO, Principal Financial Officer & Acting Chairman of the Board 1967
Mr. Daron G. Evans M.B.A., M.S. Chief Financial Officer 1974
Dr. Brian Kenneth Roberts M.D. Chief Medical Officer 1975
Dr. Davelyn Eaves Hood M.B.A., M.D. Director and Head of Scientific & Patient Affairs NA
Mr. Michael R. Deperro Senior VP & Head of Corporate Development NA
Mr. Michael Covarrubias Senior VP & Head of Program & Portfolio Management NA
Mr. Chris Milks VP & Head of Finance NA
Dr. Raj Agrawal M.D. VP & Head of Ophthalmological Clinical Development NA
Ms. Robyn Sweinhart VP & Head of Quality NA
Ms. Erin O'Boyle Senior VP & Head of Clinical Operations NA

Shares Statistics

▼
Shares Outstanding: 92.73M
Shares Float: 64.67M
% Insiders: 1,051.90%
% Institutions: 11,044.40%
Short % Float: 20.23%

Valuation Metrics

▼
Enterprise Value: $82.01M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $232.75M
EBITDA: $-82.74M
Book Value: $1.62
Earnings/Share: $-0.90
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -36.68%
ROE (TTM): -59.23%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 0.00 -0.19 N/A 10,000.00%
Sep 30, 2025 -0.18 -0.22 N/A 1,818.18%
Jun 30, 2025 -0.26 -0.21 N/A -2,189.40%
Mar 31, 2025 -0.27 -0.24 N/A -1,250.00%
Dec 31, 2024 -0.22 -0.26 N/A 1,538.46%
Sep 30, 2024 -0.22 -0.33 N/A 3,333.33%
Jun 30, 2024 -0.44 -0.33 N/A -3,333.33%
Mar 31, 2024 -0.34 -0.30 N/A -1,333.33%
Dec 31, 2023 -0.27 -0.30 N/A 1,000.00%
Sep 30, 2023 -0.28 -0.28 N/A 0.00%
Jun 30, 2023 -0.25 -0.36 N/A 3,055.56%
Mar 31, 2023 -0.30 -0.30 N/A 0.00%
Dec 31, 2022 -0.26 -0.32 N/A 1,875.00%
Sep 30, 2022 -0.19 -0.38 N/A 5,000.00%
Jun 30, 2022 -0.37 -0.41 N/A 975.61%
Mar 31, 2022 -0.65 -0.91 N/A 2,857.14%
Dec 31, 2021 -0.80 -0.69 N/A -1,594.20%
Sep 30, 2021 -0.92 -0.90 N/A -222.22%
Jun 30, 2021 -0.78 -0.80 N/A 250.00%
Mar 31, 2021 -0.44 -0.78 N/A 4,358.97%
Dec 31, 2020 -0.88 -0.75 N/A -1,733.33%
Sep 30, 2020 -0.62 -0.84 N/A 2,619.05%
Jun 30, 2020 -0.61 -0.61 N/A 81.97%
Mar 31, 2020 -1.00 -1.00 N/A 0.00%
Dec 31, 2019 -1.00 -1.00 N/A 0.00%
Sep 30, 2019 -1.00 -1.00 N/A 0.00%
Jun 30, 2019 -2.00 -1.50 N/A -3,333.33%
Mar 31, 2019 -0.32 N/A N/A N/A
Dec 31, 2018 -0.07 N/A N/A N/A
Sep 30, 2018 -0.20 N/A N/A N/A
Jun 30, 2018 -10.50 N/A N/A N/A
Mar 31, 2018 -0.09 N/A N/A N/A
Dec 31, 2017 -0.11 N/A N/A N/A
Sep 30, 2017 -0.13 N/A N/A N/A
Jun 30, 2017 -0.13 N/A N/A N/A
Mar 31, 2017 -10.36 N/A N/A N/A
Dec 31, 2016 -5.99 N/A N/A N/A
Sep 30, 2016 -5.39 N/A N/A N/A
Jun 30, 2016 -19.00 -7.50 N/A -15,333.33%
Mar 31, 2016 -7.50 -9.00 N/A 1,666.67%
Dec 31, 2015 -8.50 -7.50 N/A -1,333.33%
Sep 30, 2015 -6.75 N/A N/A N/A
Jun 30, 2015 -6.24 N/A N/A N/A
Mar 31, 2015 -7.04 N/A N/A N/A
Dec 31, 2014 -7.77 N/A N/A N/A
Sep 30, 2014 -6.11 N/A N/A N/A
Jun 30, 2014 -0.11 N/A N/A N/A
Mar 31, 2014 -4.58 N/A N/A N/A
Dec 31, 2013 -0.27 N/A N/A N/A
Sep 30, 2013 -0.12 N/A N/A N/A
Jun 30, 2013 -0.15 N/A N/A N/A
Mar 31, 2013 -35.41 N/A N/A N/A
Dec 31, 2012 -0.02 N/A N/A N/A
Sep 30, 2012 -0.12 N/A N/A N/A

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2025-06-30 $94.11M $N/A $175.49M $13.36M $162.13M
2024-06-30 $70.40M $N/A $132.74M $11.73M $121.00M
2023-06-30 $16.04M $N/A $123.72M $7.55M $116.17M
2022-06-30 $150.41M $N/A $152.42M $2.95M $149.47M
2021-06-30 $41.05M $N/A $42.61M $16.51M $26.10M
2020-06-30 $9.96M $N/A $10.97M $3.60M $7.37M
2019-06-30 $11.57M $N/A $12.25M $10.50M $1.75M
2018-06-30 $1.65M $N/A $2.50M $6.46M $-3.96M
2017-06-30 $4.49M $N/A $10.63M $2.10M $8.53M
2016-06-30 $4.06M $N/A $10.90M $2.13M $8.77M
2015-06-30 $5.28M $N/A $11.26M $2.21M $9.05M
2014-06-30 $5.93M $N/A $7.40M $997.92K $6.41M
2013-06-30 $527.00 $N/A $1.10M $5.27M $-4.16M
2012-06-30 $5.13K $N/A $5.13K $10.55K $-5.41K

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jun 25, 2025 N/A N/A N/A N/A N/A N/A
Jun 24, 2025 N/A N/A N/A N/A N/A N/A
Jun 13, 2025 N/A N/A N/A N/A N/A N/A
Jun 13, 2025 N/A N/A N/A N/A N/A N/A
Mar 31, 2025 N/A N/A N/A N/A N/A N/A
Mar 27, 2025 N/A N/A N/A N/A N/A N/A
Mar 26, 2025 N/A N/A N/A N/A N/A N/A
Feb 18, 2025 N/A N/A N/A N/A N/A N/A
Dec 18, 2024 N/A N/A N/A N/A N/A N/A
Dec 12, 2024 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist